Best of the Week
Most Popular
1. TESLA! Cathy Wood ARK Funds Bubble BURSTS! - 12th May 21
2.Stock Market Entering Early Summer Correction Trend Forecast - 10th May 21
3.GOLD GDX, HUI Stocks - Will Paradise Turn into a Dystopia? - 11th May 21
4.Crypto Bubble Bursts! Nicehash Suspends Coinbase Withdrawals, Bitcoin, Ethereum Bear Market Begins - 16th May 21
5.Crypto Bubble BURSTS! BTC, ETH, XRP CRASH! NiceHash Seizes Funds on Account Halting ALL Withdrawals! - 19th May 21
6.Cathy Wood Ark Invest Funds Bubble BURSTS! ARKK, ARKG, Tesla Entering Severe Bear Market - 13th May 21
7.Stock Market - Should You Be In Cash Right Now? - 17th May 21
8.Gold to Benefit from Mounting US Debt Pile - 14th May 21
9.Coronavius Covid-19 in Italy in August 2019! - 13th May 21
10.How to Invest in HIGH RISK Tech Stocks for 2021 and Beyond - Part 2 of 2 - 18th May 21
Last 7 days
An Update on the End of College… and a New Way to Profit - 16th Sep 21
What Kind of Support and Services Can Your Accountant Provide? Your Main Questions Answered - 16th Sep 21
Consistent performance makes waste a good place to buy stocks - 16th Sep 21
Dow Stock Market Trend Forecasting Neural Nets Pattern Recognition - 15th Sep 21
Eurozone Impact on Gold: The ECB and the Phantom Taper - 15th Sep 21
Fed To Taper into Weakening Economy - 15th Sep 21
Gold Miners: Last of the Summer Wine - 15th Sep 21
How does product development affect a company’s market value? - 15th Sep 21
Types of Investment Property to Become Familiar with - 15th Sep 21
Is This the "Kiss of Death" for the Stocks Bull Market? - 14th Sep 21
Where Are the Stock Market Fireworks? - 14th Sep 21
Play-To-Earn Cryptocurrency Games Gain More and Is Set to Expand - 14th Sep 21
The CashFX TAP Platform - Catering to Bull Investors and Bear Investors Alike - 14th Sep 21
Why every serious investor should be focused on blockchain technology - 13th Sep 21
SPX Base Projection Reached – End of the Line? - 13th Sep 21
There are diverse ways to finance the purchase of a car - 13th Sep 21
6 Tips For Wise Investment - 13th Sep 21 - Mark_Adan
Gold Price Back Below $1,800! - 10th Sep 21
The Inflation/Deflation debate wears on… - 10th Sep 21
Silver Price seen tracking Copper prices higher - 10th Sep 21
The Pitfalls of Not Using a Solicitor for Your Divorce - 10th Sep 21
Investing in a Bubble Mania Stock Market Trending Towards Financial Crisis 2.0 CRASH! - 9th Sep 21
This Boom-Bust Cycle in US Home Ownership Should Give Home Shoppers Pause - 9th Sep 21
Stock Market September Smackdown Coming Next? - 9th Sep 21 - Monica_Kingsley
Crazy Crypto Markets How to Buy Bitcoin, Litecoin for Half Market Price and Sell for TRIPLE! - 8th Sep 21
Sun Sea and Sand UK Holidays 2021, Scarborough in VR 180 3D! - 8th Sep 21
Bitcoin BTC Price Detailed Trend Forecast Into End 2021 - 8th Sep 21
Hyper Growth Stocks - This billionaire is now using one of our top strategies - 8th Sep 21
6 common trading mistakes to avoid at all costs - 8th Sep 21
US Dollar Upswing, S&P 500 and Nasdaq Outlook - 7th Sep 21
Dovish Assassins of the USD Index - 7th Sep 21
Weak August Payrolls: Why We Should Care - 7th Sep 21
A Mixed Stock Market - Still - 6th Sep 21
Energy Metals Build Momentum; Silver & Platinum May Follow - 6th Sep 21
What‘s Not to Love About Crypto Market Fireworks - 6th Sep 21
Surging US Home Prices and Gold – What’s the Link? - 6th Sep 21
S&P 500 Rallies To New All-Time Highs – Are The Markets About To Break Higher? - 5th Sep 21
Bond Conundrum - Boom or Bust for Gold? - 5th Sep 21
How the sale of a Sting CD sparked an Entire Online Industry - 5th Sep 21
Three Years of Fresh Thinking With Scott Dylan and Dave Antrobus - 5th Sep 21
Bitcoin Bear Market Trend Forecast 2021 and Model Crypto Portfolio Buying Levels - 4th Sep 21
The Most Actively Traded Companies on the Toronto Stock Exchange - 4th Sep 21

Market Oracle FREE Newsletter

Category: BioTech

The analysis published under this category are as follows.

Companies

Monday, May 04, 2020

The Biotech Boom May Have Only Just Begun / Companies / BioTech

By: Submissions

“The world is moving so fast these days that the man who says it can't be done is generally interrupted by someone doing it.” ― Elbert Hubbard

A new medical development is sweeping the country…

Some may see it as controversial - but the studies don’t lie.

It’s effective.

So effective, in fact, that the FDA has just fast-tracked approval for research…

Meaning that it is aiming to gain a major stake in a key healthcare market that is on track to hit $260 billion in the next six years.

Read full article... Read full article...

 


Saturday, February 15, 2020

iShares Nasdaq Biotechnology ETF IBB AI Mega-trend Tech Stocks Investing 2020 / / BioTech

By: Nadeem_Walayat

The juggernaut that is Artificial Intelligence continues to rumble along towards an inexorable future, one that most still fail to grasp the magnitude of the changes that are just around the corner as humans think in linear terms whilst the AI trend is EXPONENTIAL. Where developments that even the proponents of AI thought would take several years are taking place in mere MONTHS! That is the power of the unfolding AI MEGA-TREND!

AI has already CHANGED THE WORLD! EXPONENTIALLY! You have an AI super computer right in your pocket for likely less than £1000!

Especially, when one marries AI with other big world changing tech mega-trend "Quantum Computing"! Put the 2 together and we are literally going to see an explosion in SUPER INTELLGENCE that would soon far exceed that of human intelligence, following which it won't be that many years before the AI exceeds the intelligence of the sum of ALL humans! For better or worse, that's the path we are on.

And all those who say AI can be controlled are going to be proven wrong, as new technologies tend to be first sequestered towards military aims. So whilst we focus on the benefits of AI in reality AI is a POWERFUL WEAPON and so the world is in an AI arms race, commercial, economic and military AI arms race.

Read full article... Read full article...

 


Companies

Wednesday, August 28, 2019

Highly Undervalued Biotechnology Stocks To Watch / Companies / BioTech

By: Joshua_Rodriguez

The biotechnology industry is an exciting one. As continued innovation drives a better scientific understanding of the human body and the ailments that weigh on it, we are seeing better outcomes for patients who are living longer, more fulfilling lives.

However, it’s not only the patients that are seeing tremendous benefit out of this innovation. Investors are benefiting greatly as well. After all, as new medications hit the market, tremendous revenue opportunities are being created for the companies creating these treatments.
Read full article... Read full article...

 


Companies

Saturday, July 27, 2019

Human Life Extension Investing in IBB - iShares Nasdaq Biotechnology ETF - IBB / Companies / BioTech

By: Nadeem_Walayat

We are currently galloping full speed along an exponential curve that unlike the neural nets of the 1990's, that promised a lot but delivered very little, this time it really looks like we are on the verge of AI success, not only that but it heralds changes in every aspect of our lives most of which we cannot even imagine today, hence the term the singularity is often used, the AI event horizon beyond which we cannot see.

My latest analysis in this series focuses on how to profit and capitalise on the unfolding machine intelligence driven mega-trend through investing in leveraged to AI Human Life Extension stocks.

Read full article... Read full article...

 


Companies

Thursday, July 18, 2019

Biotech Stocks With Near Term Catalysts / Companies / BioTech

By: Joshua_Rodriguez

Medical innovation is an incredible thing. In fact, as we continue to better understand the human body and cutting-edge biotechnology companies continue to produce innovative medicines, the average life expectancy in human beings is growing at a rate of about two months every year.

Not only is this innovation in medicine leading to a better quality of life and longer lifespan for countless patients, it is also leading strong investment opportunities. Driven by the fact that there are multiple catalysts along the process of drug development and incredible value once new drugs are approved, investor interest in the field of biotechnology is running high.

Read full article... Read full article...

 


Companies

Wednesday, April 17, 2019

Elliott Wave Analysis of XBI (Biotech ETF) / Companies / BioTech

By: WavePatternTraders

This is one area of the market that is actually showing some weakness compared to the NDX and SPX, so it could be a warning for both those markets. The reversal from the last minor swing high at $93.87 could be favoring a peak in place, although I would still allow for a bit more upside to end wave [B] if needed.

As long as it fails to make a new high above $101.52, then it has a bearish setup for a move lower and tests $60.00 - 55.00 to end wave [C] to complete a large 3 wave decline from $101.52.

Bearish below $101.52, but tentatively looking lower below $93.87.
Read full article... Read full article...

 


Companies

Monday, April 08, 2019

5 Biotech Stocks That You Should Be Watching Right Now! / Companies / BioTech

By: Submissions

The world of biotechnology is changing rapidly. Today, there are more answers for medical questions than ever before. However, that doesn’t mean that innovation is coming to an end. Several companies dedicate their efforts to finding solutions for some of the world’s most debilitating conditions.

This medical innovation has led to droves of investor interest. As more and more companies find solutions, more and more investors are finding profits. However, as with any investment, investing in the biotechnology space can come with risk.

Read full article... Read full article...

 


Companies

Friday, November 23, 2018

DNA Breakthrough: Scientists Repair Genes in Human Embryos / Companies / BioTech

By: Andrew_Cioffi

The medical field is set to change tremendously owing to a recent breakthrough by medical researchers. A team of researchers recently managed to use gene-editing tools to remove mutations in embryos which develop into human diseases. The team that comprised of the Oregon Health and Science University and other researchers were able to make breakthrough discoveries. The particular disease, hypertrophic cardiomyopathy, is passed down genetically and is a cause of many deaths especially among young athletes. It is not clear yet as to when the technology will be applied in the real world.

Read full article... Read full article...

 


Companies

Thursday, May 03, 2018

4 Biotech Stock Movers to Watch / Companies / BioTech

By: Harry_Boxer

Biotechs continue to dominate our list of top charts to watch.

CASI Pharmaceuticals Inc. (CASI) rose 48 cents, or 7.2%, to $7.14 on 773,700 shares Tuesday. The move came on no news, although the stock soared in early April on news that China's Food and Drug Administration (CFDA) would convene a panel to discuss its cancer therapy, Evomela. The stock has been flagging since that move, but may be positioning to break out, with the next target at $10.

Read full article... Read full article...

 


Companies

Monday, September 11, 2017

Could This Be The Biggest Biotech Breakthrough Of The Year? / Companies / BioTech

By: OilPrice_Com

Someone dies of a stroke every 4 minutes in the United States. Globally, 15 million people suffer a stroke every year. It’s debilitating physically and financially—but one little-known company has developed a medical device that hopes to challenge that deadly statistic.

It’s been quietly developing this new technology for 10 years. Now it’s released updated preliminary clinical trial results, and signed a manufacturing deal which could make a significant impact in the medical device industry.

After a decade of painstaking development, we’re now nearing the end of the long road to validation, and for investors who understand this industry, this could be the critical juncture.

Read full article... Read full article...

 


Companies

Wednesday, July 19, 2017

Biotech with Alzheimer's Focus Makes Progress on Several Fronts / Companies / BioTech

By: TLSReport

In its corporate update for Q2/17, a Canada-based biotech targeting neurological disorders including Alzheimer's disease informed investors of advancements in several programs, including designation of a second validated lead compound in development.

Among ProMIS Neurosciences Inc.'s (PMN:TSE) "key accomplishments" in the quarter, the company noted it expanded its potentially "best in class amyloid-beta (Aβ) portfolio for Alzheimer's disease," according to a July 10 news release. In its oral presentation, the company stressed its emphasis on the "best in class" goal, noting that even though Biogen Inc.'s (BIIB:NASDAQ) aducanumab will be "first in class" and is progressing well in development, the ProMIS compound could be more selective and possess greater patient benefits.

Read full article... Read full article...

 


Companies

Sunday, April 23, 2017

After The Crash - Digital And Regenerative Medicine, Live for Ever! / Companies / BioTech

By: John_Rubino

For most people, the doctor visit hasn’t changed in decades. Same physical waiting rooms, same paper forms to fill out, same slow, expensive tests and marginally-effective, maximally-invasive treatments. But that’s about to change, as a wave of new technologies drag medicine into the 21st century. Among the most interesting:

Read full article... Read full article...

 


Companies

Tuesday, April 18, 2017

The Smart Money Is Piling Into Regenerative Medicine / Companies / BioTech

By: John_Mauldin

BY PATRICK COX : The Congressional Budget Office released its long-term budget outlook. This report should have sparked a national discussion about societal aging, but big media largely ignored it.

Fortunately, there are signs that smart investors are hedging this failure by investing in regenerative medicine (RM).

Read full article... Read full article...

 


Companies

Wednesday, April 05, 2017

British Billionaire Jim Mellon Says Biotech Is the Best Investment Now / Companies / BioTech

By: John_Mauldin

BY PATRICK COX : We are in the midst of an unprecedented change. Life spans have nearly doubled since the beginning of the 20th century. In addition, recent advances in computer technology have had a huge impact on biological sciences, which means this trend will accelerate.

Still, most people think that the process of aging will go on pretty much as it is now. They’re wrong.

Read full article... Read full article...

 


Companies

Monday, March 13, 2017

... / Companies / BioTech

By: OilPrice_Com

...

 


Companies

Tuesday, February 28, 2017

Major Funds Betting On Trump BioTech Sector / Companies / BioTech

By: TLSReport

Donald Trump's presidency is a real nitro boost for the future of the biotech sector in the U.S., says Tom Beck, editor of Portfolio Wealth Global.

Donald Trump's presidency is a massive boost to all industries, and is a real nitro boost for the future of the biotech sector in the U.S.

With 80 million baby-boomers looking to stay young and vital for a very long time, you should be making your move, and market-beating returns will be occurring from the large-cap stocks and in the small-cap sector even more so.

Read full article... Read full article...

 


Companies

Tuesday, January 24, 2017

The Last Time This Happened, Biotech Stocks Plunged by 50% / Companies / BioTech

By: John_Mauldin

BY PATRICK WATSON : “They’re getting away with murder,” said Donald Trump at last week’s epic news conference.

No, he didn’t mean Russian hackers. He was talking about red-blooded American drug companies.

Trump went on: “Pharma has a lot of lobbyists and a lot of power, and there is very little bidding. We’re the largest buyer of drugs in the world, and yet we don’t bid properly, and we’re going to save billions of dollars.”

Read full article... Read full article...

 


Companies

Wednesday, January 18, 2017

Biotech Breakthrough Could Create A $11.4 Trillion Opportunity / Companies / BioTech

By: OilPrice_Com

....

 


Companies

Saturday, December 03, 2016

Can Biotech's Trump Bump Last? / Companies / BioTech

By: TLSReport

In the weeks since Donald Trump's presidential election victory, the stock markets have ridden a wave into positive—and in the case of the Dow, record-breaking—territory. The so-called Trump Bump also sent biotech indices, flaccid for much of the year, up as much as 15%. With the election now nearly a month old, and hot-button issues such as drug pricing still in the press, industry watchers have begun to weigh in on what might happen in the biotech and pharma markets when Trump takes office.

Read full article... Read full article...

 


Economics

Monday, November 21, 2016

Trump Can Fix US Economy by Embracing Biotech / Economics / BioTech

By: John_Mauldin

BY PATRICK COX : The presidential campaign made one fact very clear. Most of the media and public aren't focused on economic growth.

Growth powers and funds everything else. Just take a look at the enormous federal deficit and you’ll see that economic health keeps taking a back seat to short-term goals.

Yes, John Maynard Keynes made a case for using debt to stimulate the economy. But he never said anything about permanent deficits. And that is our current practice. The result is that taxpayers’ options will be curtailed in the future.

Read full article... Read full article...

 


Page << | 1 | 2 | 3 | 4 | 5 | >>